(Q83656563)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

review article

1 reference

reason for deprecated rank

title

¿Por qué micafungina puede ser de elección en el paciente pediátrico? (Spanish)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70005-2

reason for deprecated rank

27 November 2024

Why might micafungin be the drug of choice in pediatric patients? (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21420573

27 November 2024

author name string

José Tomás Ramos Amador

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Luis Prieto Tato

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sara Guillén Martín

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

Spanish

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21420573

27 November 2024

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21420573

full work available at URL

27 November 2024

https://api.elsevier.com/content/article/PII:S0213005X11700052?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70005-2

https://api.elsevier.com/content/article/PII:S0213005X11700052?httpAccept=text/plain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70005-2

Infectious Diseases and Clinical Microbiology

27 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

29 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

23-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

Mycoses in pediatric patients

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

A clinical review of echinocandins in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

[Micafungin in pediatric and adolescent patients].

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Linear pharmacokinetics of micafungin and its active metabolites in Japanese pediatric patients with fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Pharmacokinetics of an elevated dosage of micafungin in premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Population pharmacokinetics of micafungin in neonates and young infants

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Antifungal prophylaxis with micafungin in patients treated for childhood cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Treatment of invasive candidal infections: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2811%2970005-2

7 January 2021

Safety and pharmacokinetics of repeat-dose micafungin in young infants

15

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70005-2

Pooled analysis of safety for micafungin

27 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0213-005X(11)70005-2

27 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21420573%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference